Current Challenges for HER2 Testing in Diagnostic Pathology: State of the Art and Controversial Issues

HER2 overexpression and anti-HER2 agents represent probably the best story of success of individualized therapy in breast cancer. Due to the important therapeutic implications, the issue under the spotlight has been, since ever, the correct identification of true HER2 positivity on tissue specimens....

Descripción completa

Detalles Bibliográficos
Autores principales: Sapino, Anna, Goia, Margherita, Recupero, Daniele, Marchiò, Caterina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659312/
https://www.ncbi.nlm.nih.gov/pubmed/23734345
http://dx.doi.org/10.3389/fonc.2013.00129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659312/
https://www.ncbi.nlm.nih.gov/pubmed/23734345
http://dx.doi.org/10.3389/fonc.2013.00129

Ejemplares similares